Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial
Indian Journal of Ophthalmology · 2025
DOI: 10.4103/ijo.ijo_345_24 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Esmaeil Babaei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Trabeculectomy, Cyclosporine, Intraocular Pressure, Glaucoma, Open-Angle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Purpose
To investigate the effect of cyclosporine A 2% eye drop following trabeculectomy on intraocular pressure (IOP) and surgical success compared to postoperative steroid drop. Study Design: Prospective, randomized clinical trial in an institutional setting.
Methods
Patients: Forty patients with primary open-angle glaucoma and candidates for trabeculectomy were included in this study. Standard fornix-based trabeculectomy augmented with mitomycin C was performed for all patients. None of the included subjects had a history of prior laser or intraocular surgery in that eye.
Intervention
All included subjects were randomly assigned to either postoperative cyclosporine A 2% or betamethasone 0.1% eye drops. Main Outcome Measures: IOP measured by applanation tonometer and surgical success rate.
Results
Seventy-five potentially eligible POAG patients were seen during the study period, and 40 met the study criteria and were randomly assigned to one of the study groups. Patients in the cyclosporine A 2% group had consistently lower IOP, fewer glaucoma medications, and higher success rates for at least 24 months after surgery ( P < 0.0001). Complete success was more frequent in the cyclosporine group. Moreover, the cyclosporine A group had more diffuse and elevated bleb with less vascularity in the first 3 months after surgery ( P ≤ 0.01). This was paralleled with fewer dry eye signs and symptoms in the cyclosporine group in the first 3 months ( P < 0.03).
Conclusion
Postoperative cyclosporine A 2% eye drop can be used instead of steroid drops and is associated with improved surgical success and decreased dry eye manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Ophthalmology, University of Florida, Gainesville, Florida, USA.
Zitieren
APA
Babaei, E., Eslampoor, A., & Daneshvar, R. (2025). Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_345_24
Vancouver
Babaei E, Eslampoor A, Daneshvar R. Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial. Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_345_24
BibTeX
@article{Babaei2025,
author = {Babaei, Esmaeil and Eslampoor, Alireza and Daneshvar, Ramin},
title = {Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial},
journal = {Indian Journal of Ophthalmology},
year = {2025},
doi = {10.4103/ijo.ijo_345_24}
}
EUVIMED